KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
77 hedge funds and large institutions have $106M invested in Kindred Biosciences, Inc. in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
77
Holding in Top 10
–
Calls
$10K
Puts
–
Top Buyers
| 1 | +$1.16M | |
| 2 | +$627K | |
| 3 | +$291K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$269K |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$200K |
Top Sellers
| 1 | -$471K | |
| 2 | -$401K | |
| 3 | -$348K | |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$240K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$140K |